Table 1 Pre-operative demographic and clinical characteristics of all the 88 patients undergone penile lengthening procedure with TachoSil® between 2016 and 2024 at four Portuguese hospitals.
Total | |
|---|---|
Age, years | 59.0 (56.0–63.0) |
Follow-up time, months | 31.0 (13.0–52.8) |
Preoperative IIEF-5 score | 22.5 (22.0–23.0) |
Time symptom onset-consultation, months | 12.0 (6.0–18.0) |
Time consultation-surgery, months | 8.0 (4.8–14.0) |
Time symptom-surgery, months | 21.0 (15.0–28.0) |
Comorbidity, n (%) | |
Dyslipidemia | 36 (40.9) |
Hypertension | 33 (37.5) |
Diabetes | 20 (22.7) |
Penile trauma | 9 (10.2) |
Penile surgery | 9 (10.2) |
Dupuytren’s disease | 9 (10.2) |
Pelvic surgery | 3 (3.4) |
Ledderhose disease | - |
Use of pre-operative penile ultrasound, n (%) | 63 (71.6) |
Anatomic distribution of curvature, n (%) | |
Dorsal | 58 (65.9) |
Ventral | 1 (1.1) |
Left | 4 (4.5) |
Dorsal+Left | 24 (27.3) |
Hourglass | 29 (33.0) |
Proximal third | 21 (23.9) |
Medium third | 40 (45.5) |
Distal third | 27 (30.7) |
Type of plaque’s surgical approach, n (%) | |
H-fashion incision | 39 (44.3) |
Y-fashion incision | 23 (26.1) |
I-fashion incision | 10 (11.6) |
Complete excision | 7 (8.0) |
180° incision | 3 (3.4) |
Unknown | 6 (6.9) |
Curvature angle, degrees | 80.0 (78.8–90.0) |
Surgical procedure timing, minutes | 92.5 (80.0–106.3) |
SPL – preoperative, cm | 13.0 (12.0–14.0) |
SPL – intra-operative after correction, cm | 13.8 (12.5-15.0) |
SPL – 1 month after surgery, cm | 14.0 (13.0–15.0) |
SPL – difference between preoperative and 1 month after surgery | 1.0 (0.8–2.0) |
Postoperative IIEF-5 score | 20.0 (16.0–22.0) |
IIEF-5 score difference | −5.5 (−7.0 to −1.0) |
